Company profile INDP
After 38 days of this quarter the interest is at 20.0. Based on that we can calculate that during remaining 53 days it will total up to 48.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 48 | 31 -35.4% QoQ | 22 -29.0% QoQ | 15 -31.8% QoQ |
| 2020 | 75 56.2% YoY 400.0% QoQ | 12 -61.3% YoY -84.0% QoQ | 157 613.6% YoY 1208.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 44 -41.3% YoY inf% QoQ | 31 158.3% YoY -29.5% QoQ | 190 21.0% YoY 512.9% QoQ | 47 inf% YoY -75.3% QoQ |
| 2022 | 53 20.5% YoY 12.8% QoQ | 38 22.6% YoY -28.3% QoQ | 88 -53.7% YoY 131.6% QoQ | 60 27.7% YoY -31.8% QoQ |
| 2023 | 60 13.2% YoY 0.0% QoQ | 132 247.4% YoY 120.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 54 -10.0% YoY inf% QoQ |
| 2024 | 20 -66.7% YoY -63.0% QoQ | - | - | - |
The average 5 years interest of Indaptus Therapeutics was 4.53 per week. The last year interest of Indaptus Therapeutics compared to the last 5 years has changed by -6.62%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 59.62%.
There is not enough data for Indaptus Therapeutics clinical trials to provide analysis
There is not enough data for Indaptus Therapeutics clinical trials to provide correlation calculation
There is not enough data for Indaptus Therapeutics clinical trials to provide analysis
There is not enough data for Decoy20 immunotherapy to provide analysis
There is not enough data for Decoy20 immunotherapy to provide correlation calculation
There is not enough data for Decoy20 immunotherapy to provide analysis
After 38 days of this quarter the interest is at 289.0. Based on that we can calculate that during remaining 53 days it will total up to 692.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 516 | 974 88.8% QoQ | 948 -2.7% QoQ | 869 -8.3% QoQ |
| 2020 | 851 64.9% YoY -2.1% QoQ | 742 -23.8% YoY -12.8% QoQ | 807 -14.9% YoY 8.8% QoQ | 778 -10.5% YoY -3.6% QoQ |
| 2021 | 779 -8.5% YoY 0.1% QoQ | 853 15.0% YoY 9.5% QoQ | 870 7.8% YoY 2.0% QoQ | 821 5.5% YoY -5.6% QoQ |
| 2022 | 865 11.0% YoY 5.4% QoQ | 883 3.5% YoY 2.1% QoQ | 820 -5.7% YoY -7.1% QoQ | 816 -0.6% YoY -0.5% QoQ |
| 2023 | 922 6.6% YoY 13.0% QoQ | 938 6.2% YoY 1.7% QoQ | 870 6.1% YoY -7.2% QoQ | 940 15.2% YoY 8.0% QoQ |
| 2024 | 289 -68.7% YoY -69.3% QoQ | - | - | - |
The average 5 years interest of lymphoma treatment was 65.97 per week. The last year interest of lymphoma treatment compared to the last 5 years has changed by 5.5%. The interest for lymphoma treatment is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -1.28%.
There is not enough data for hepatocellular tumor therapy to provide analysis
There is not enough data for hepatocellular tumor therapy to provide correlation calculation
There is not enough data for hepatocellular tumor therapy to provide analysis
After 38 days of this quarter the interest is at 116.0. Based on that we can calculate that during remaining 53 days it will total up to 278.0. colorectal cancer therapy expected interest is significantly higher compared to same quarter last year (+100.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 107 | 141 31.8% QoQ | 57 -59.6% QoQ | 143 150.9% QoQ |
| 2020 | 171 59.8% YoY 19.6% QoQ | 182 29.1% YoY 6.4% QoQ | 148 159.6% YoY -18.7% QoQ | 136 -4.9% YoY -8.1% QoQ |
| 2021 | 207 21.1% YoY 52.2% QoQ | 109 -40.1% YoY -47.3% QoQ | 111 -25.0% YoY 1.8% QoQ | 85 -37.5% YoY -23.4% QoQ |
| 2022 | 250 20.8% YoY 194.1% QoQ | 311 185.3% YoY 24.4% QoQ | 150 35.1% YoY -51.8% QoQ | 90 5.9% YoY -40.0% QoQ |
| 2023 | 139 -44.4% YoY 54.4% QoQ | 172 -44.7% YoY 23.7% QoQ | 236 57.3% YoY 37.2% QoQ | 277 207.8% YoY 17.4% QoQ |
| 2024 | 116 -16.5% YoY -58.1% QoQ | - | - | - |
The average 5 years interest of colorectal cancer therapy was 12.84 per week. The last year interest of colorectal cancer therapy compared to the last 5 years has changed by 31.23%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 75.52%.
After 38 days of this quarter the interest is at 169.0. Based on that we can calculate that during remaining 53 days it will total up to 405.0. pancreatic tumor treatment expected interest is significantly higher compared to same quarter last year (+45.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 214 | 330 54.2% QoQ | 275 -16.7% QoQ | 233 -15.3% QoQ |
| 2020 | 169 -21.0% YoY -27.5% QoQ | 212 -35.8% YoY 25.4% QoQ | 170 -38.2% YoY -19.8% QoQ | 89 -61.8% YoY -47.6% QoQ |
| 2021 | 74 -56.2% YoY -16.9% QoQ | 139 -34.4% YoY 87.8% QoQ | 109 -35.9% YoY -21.6% QoQ | 210 136.0% YoY 92.7% QoQ |
| 2022 | 143 93.2% YoY -31.9% QoQ | 430 209.4% YoY 200.7% QoQ | 168 54.1% YoY -60.9% QoQ | 281 33.8% YoY 67.3% QoQ |
| 2023 | 279 95.1% YoY -0.7% QoQ | 369 -14.2% YoY 32.3% QoQ | 218 29.8% YoY -40.9% QoQ | 300 6.8% YoY 37.6% QoQ |
| 2024 | 169 -39.4% YoY -43.7% QoQ | - | - | - |
The average 5 years interest of pancreatic tumor treatment was 17.62 per week. The last year interest of pancreatic tumor treatment compared to the last 5 years has changed by 39.39%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 14.02%.
There is not enough data for chronic hepatitis B virus therapy to provide analysis
There is not enough data for chronic hepatitis B virus therapy to provide correlation calculation
There is not enough data for chronic hepatitis B virus therapy to provide analysis
After 38 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 53 days it will total up to 50.0. human immunodeficiency virus treatment expected interest is significantly lower compared to previous quarter (-45.1%) and same quarter last year (-74.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 19 | 0 -100.0% QoQ | 99 inf% QoQ | 60 -39.4% QoQ |
| 2020 | 146 668.4% YoY 143.3% QoQ | 143 inf% YoY -2.1% QoQ | 31 -68.7% YoY -78.3% QoQ | 55 -8.3% YoY 77.4% QoQ |
| 2021 | 49 -66.4% YoY -10.9% QoQ | 137 -4.2% YoY 179.6% QoQ | 31 0.0% YoY -77.4% QoQ | 48 -12.7% YoY 54.8% QoQ |
| 2022 | 69 40.8% YoY 43.8% QoQ | 85 -38.0% YoY 23.2% QoQ | 44 41.9% YoY -48.2% QoQ | 172 258.3% YoY 290.9% QoQ |
| 2023 | 194 181.2% YoY 12.8% QoQ | 215 152.9% YoY 10.8% QoQ | 167 279.5% YoY -22.3% QoQ | 91 -47.1% YoY -45.5% QoQ |
| 2024 | 21 -89.2% YoY -76.9% QoQ | - | - | - |
The average 5 years interest of human immunodeficiency virus treatment was 7.22 per week. The last year interest of human immunodeficiency virus treatment compared to the last 5 years has changed by 56.37%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 136.69%.
There is not enough data for Indaptus Therapeutics stock to provide analysis
There is not enough data for Indaptus Therapeutics stock to provide correlation calculation
There is not enough data for Indaptus Therapeutics stock to provide analysis
After 39 days of this quarter the interest is at 222.0. Based on that we can calculate that during remaining 52 days it will total up to 518.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 268 | 380 41.8% QoQ | 216 -43.2% QoQ | 353 63.4% QoQ |
| 2020 | 362 35.1% YoY 2.5% QoQ | 308 -18.9% YoY -14.9% QoQ | 327 51.4% YoY 6.2% QoQ | 302 -14.4% YoY -7.6% QoQ |
| 2021 | 336 -7.2% YoY 11.3% QoQ | 338 9.7% YoY 0.6% QoQ | 303 -7.3% YoY -10.4% QoQ | 311 3.0% YoY 2.6% QoQ |
| 2022 | 398 18.5% YoY 28.0% QoQ | 455 34.6% YoY 14.3% QoQ | 395 30.4% YoY -13.2% QoQ | 369 18.6% YoY -6.6% QoQ |
| 2023 | 510 28.1% YoY 38.2% QoQ | 445 -2.2% YoY -12.7% QoQ | 316 -20.0% YoY -29.0% QoQ | 488 32.2% YoY 54.4% QoQ |
| 2024 | 222 -56.5% YoY -54.5% QoQ | - | - | - |
The average 5 years interest of biotechnology industry was 28.36 per week. The last year interest of biotechnology industry compared to the last 5 years has changed by 22.07%. The interest for biotechnology industry is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 29.61%.
After 39 days of this quarter the interest is at 349.0. Based on that we can calculate that during remaining 52 days it will total up to 814.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 324 | 608 87.7% QoQ | 438 -28.0% QoQ | 515 17.6% QoQ |
| 2020 | 627 93.5% YoY 21.7% QoQ | 640 5.3% YoY 2.1% QoQ | 546 24.7% YoY -14.7% QoQ | 506 -1.7% YoY -7.3% QoQ |
| 2021 | 670 6.9% YoY 32.4% QoQ | 469 -26.7% YoY -30.0% QoQ | 438 -19.8% YoY -6.6% QoQ | 438 -13.4% YoY 0.0% QoQ |
| 2022 | 804 20.0% YoY 83.6% QoQ | 638 36.0% YoY -20.6% QoQ | 571 30.4% YoY -10.5% QoQ | 710 62.1% YoY 24.3% QoQ |
| 2023 | 788 -2.0% YoY 11.0% QoQ | 622 -2.5% YoY -21.1% QoQ | 604 5.8% YoY -2.9% QoQ | 855 20.4% YoY 41.6% QoQ |
| 2024 | 349 -55.7% YoY -59.2% QoQ | - | - | - |
The average 5 years interest of healthcare sector was 46.59 per week. The last year interest of healthcare sector compared to the last 5 years has changed by 18.22%. The interest for healthcare sector is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 37.77%.